GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Dermisonics Inc (GREY:DMSI) » Definitions » Debt-to-EBITDA

Dermisonics (Dermisonics) Debt-to-EBITDA : -1.60 (As of Jun. 2007)


View and export this data going back to . Start your Free Trial

What is Dermisonics Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Dermisonics's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2007 was $0.43 Mil. Dermisonics's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2007 was $2.22 Mil. Dermisonics's annualized EBITDA for the quarter that ended in Jun. 2007 was $-1.66 Mil. Dermisonics's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2007 was -1.60.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Dermisonics's Debt-to-EBITDA or its related term are showing as below:

DMSI's Debt-to-EBITDA is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.26
* Ranked among companies with meaningful Debt-to-EBITDA only.

Dermisonics Debt-to-EBITDA Historical Data

The historical data trend for Dermisonics's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dermisonics Debt-to-EBITDA Chart

Dermisonics Annual Data
Trend Sep03 Sep04 Sep05
Debt-to-EBITDA
- -0.63 -0.60

Dermisonics Quarterly Data
Sep03 Dec03 Mar04 Jun04 Sep04 Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.77 -0.64 -1.25 -2.60 -1.60

Competitive Comparison of Dermisonics's Debt-to-EBITDA

For the Medical Devices subindustry, Dermisonics's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dermisonics's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Dermisonics's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Dermisonics's Debt-to-EBITDA falls into.



Dermisonics Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Dermisonics's Debt-to-EBITDA for the fiscal year that ended in Sep. 2005 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(1.57 + 2.168) / -6.2
=-0.60

Dermisonics's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2007 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.433 + 2.216) / -1.656
=-1.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Jun. 2007) EBITDA data.


Dermisonics  (GREY:DMSI) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Dermisonics Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Dermisonics's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Dermisonics (Dermisonics) Business Description

Traded in Other Exchanges
N/A
Address
2360 Corporate Circle, Henderson, NV, USA, 89074
Website
Dermisonics Inc is involved in the medical technology business.

Dermisonics (Dermisonics) Headlines

No Headlines